{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:45:56Z","timestamp":1776206756516,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":1970,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271467"],"award-info":[{"award-number":["81271467"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272459"],"award-info":[{"award-number":["81272459"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30970938"],"award-info":[{"award-number":["30970938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571301"],"award-info":[{"award-number":["81571301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401105"],"award-info":[{"award-number":["81401105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the central Universities","doi-asserted-by":"crossref","award":["YJ201790"],"award-info":[{"award-number":["YJ201790"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s13311-018-0613-8","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T14:47:04Z","timestamp":1519138024000},"page":"500-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Brain Renin\u2013Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity"],"prefix":"10.1016","volume":"15","author":[{"given":"Linhong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jueying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailei","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-018-0613-8_bib1","unstructured":"Mattson M E. Emergency department visits involving methamphetamine: 2007 to 2011. The CBHSQ Report. Rockville (MD)2013."},{"key":"10.1007\/s13311-018-0613-8_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pneurobio.2015.09.011","article-title":"Amphetamine-related drugs neurotoxicity in humans and in experimental animals: main mechanisms","volume":"155","author":"Moratalla","year":"2017","journal-title":"Prog Neurobiol."},{"key":"10.1007\/s13311-018-0613-8_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neubiorev.2016.07.020","article-title":"Chronic methamphetamine self-administration disrupts cortical control of cognition","volume":"69","author":"Bernheim","year":"2016","journal-title":"Neurosci Biobehav R."},{"key":"10.1007\/s13311-018-0613-8_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1007\/s13311-018-0613-8_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.mp.4001202","article-title":"Disruption of nicotine conditioning by dopamine D3 receptor ligands","volume":"8","author":"B Le Foll","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1007\/s13311-018-0613-8_bib6","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","article-title":"Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats","volume":"22","author":"Vorel","year":"2002","journal-title":"J Neurosci."},{"key":"10.1007\/s13311-018-0613-8_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.npp.1300912","article-title":"The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats","volume":"31","author":"Xi","year":"2006","journal-title":"Neuropsychopharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrn.2016.39","article-title":"Synaptic mechanisms underlying persistent cocaine craving","volume":"17","author":"Wolf","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-018-0613-8_bib9","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1523\/JNEUROSCI.3765-09.2009","article-title":"Striatal dopamine d2\/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity","volume":"29","author":"Lee","year":"2009","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-018-0613-8_bib10","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/mp.2015.223","article-title":"Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users","volume":"21","author":"Kohno","year":"2016","journal-title":"Mol Psychiatry."},{"key":"10.1007\/s13311-018-0613-8_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/brain\/awr320","article-title":"Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system","volume":"135","author":"Rodriguez-Perez","year":"2012","journal-title":"Brain."},{"key":"10.1007\/s13311-018-0613-8_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-018-0613-8_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pneurobio.2014.11.004","article-title":"The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases","volume":"125","author":"Wright","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-018-0613-8_bib14","doi-asserted-by":"crossref","first-page":"e1002064","DOI":"10.1371\/journal.pmed.1002064","article-title":"Correction: cardiovascular and renal outcomes of renin-angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses","volume":"13","author":"Staff","year":"2016","journal-title":"PLoS Med."},{"key":"10.1007\/s13311-018-0613-8_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.regpep.2004.12.015","article-title":"Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists","volume":"128","author":"Saavedra","year":"2005","journal-title":"Regul Pept."},{"key":"10.1007\/s13311-018-0613-8_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.1996.tb15418.x","article-title":"Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo","volume":"118","author":"Brown","year":"1996","journal-title":"Br J Pharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib17","doi-asserted-by":"crossref","first-page":"26675","DOI":"10.18632\/oncotarget.5596","article-title":"Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration","volume":"6","author":"Diaz-Ruiz","year":"2015","journal-title":"Oncotarget."},{"key":"10.1007\/s13311-018-0613-8_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2017.06.017","article-title":"Beneficial effects of angiotensin II receptor blockers in brain disorders.","author":"Saavedra","year":"2017","journal-title":"Pharmacol Res."},{"key":"10.1007\/s13311-018-0613-8_bib19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bcp.2013.06.025","article-title":"Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [(3)H]dopamine and [(3)H]norepinephrine release","volume":"86","author":"Narayanaswami","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-018-0613-8_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2011040344","article-title":"Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation","volume":"23","author":"Li","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1007\/s13311-018-0613-8_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2015.05.006","article-title":"Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum","volume":"96","author":"Martinez-Pinilla","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1007\/s13311-018-0613-8_bib22","doi-asserted-by":"crossref","first-page":"534817","DOI":"10.1155\/2013\/534817","article-title":"Angiotensin II AT(1) receptors are involved in neuronal activation induced by amphetamine in a two-injection protocol","volume":"2013","author":"Paz","year":"2013","journal-title":"Biomed Res Int."},{"key":"10.1007\/s13311-018-0613-8_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/syn.20868","article-title":"The AT(1) angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol","volume":"65","author":"Paz","year":"2011","journal-title":"Synapse."},{"key":"10.1007\/s13311-018-0613-8_bib24","first-page":"314","article-title":"Involvement of the brain renin-angiotensin system (RAS) in the neuroadaptive responses induced by amphetamine in a two-injection protocol","volume":"272","author":"Paz","year":"2014","journal-title":"Behav\u00a0Brain\u00a0Res"},{"key":"10.1007\/s13311-018-0613-8_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2015.08.027","article-title":"A previous history of repeated amphetamine exposure modifies brain angiotensin II AT1 receptor functionality","volume":"307","author":"Casarsa","year":"2015","journal-title":"Neuroscience."},{"key":"10.1007\/s13311-018-0613-8_bib26","doi-asserted-by":"crossref","first-page":"12890","DOI":"10.1523\/JNEUROSCI.0246-15.2015","article-title":"Arginine methyltransferase 1 in the nucleus accumbens regulates behavioral effects of cocaine","volume":"35","author":"Li","year":"2015","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-018-0613-8_bib27","doi-asserted-by":"crossref","first-page":"H376","DOI":"10.1152\/ajpheart.00649.2014","article-title":"Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure","volume":"308","author":"Czikora","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"10.1007\/s13311-018-0613-8_bib28","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00429-012-0383-8","article-title":"Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model","volume":"217","author":"Li","year":"2012","journal-title":"Brain Struct Funct."},{"key":"10.1007\/s13311-018-0613-8_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1152\/physrev.00040.2005","article-title":"The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure","volume":"87","author":"Oliveira","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1007\/s13311-018-0613-8_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet."},{"key":"10.1007\/s13311-018-0613-8_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science."},{"key":"10.1007\/s13311-018-0613-8_bib32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJMc082129","article-title":"Telmisartan for prevention of cardiovascular events","volume":"360","author":"Fichet","year":"2009","journal-title":"New Engl J Med."},{"key":"10.1007\/s13311-018-0613-8_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1369-1600.2010.00211.x","article-title":"The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access","volume":"15","author":"Orio","year":"2010","journal-title":"Addict Biol"},{"key":"10.1007\/s13311-018-0613-8_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-007-0986-6","article-title":"The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats","volume":"196","author":"Spiller","year":"2008","journal-title":"Psychopharmacology."},{"issue":"7650","key":"10.1007\/s13311-018-0613-8_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature22035","article-title":"Structural basis for selectivity and diversity in angiotensin II receptors","volume":"544","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"10.1007\/s13311-018-0613-8_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","article-title":"Brain renin-angiotensin\u2014a new look at an old system","volume":"95","author":"Wright","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-018-0613-8_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/CIRCRESAHA.107.169110","article-title":"Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation","volume":"102","author":"Feng","year":"2008","journal-title":"Circ Res"},{"key":"10.1007\/s13311-018-0613-8_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pneurobio.2004.03.003","article-title":"The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory","volume":"72","author":"Wright","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1007\/s13311-018-0613-8_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1755-5949.2008.00057.x","article-title":"Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy","volume":"14","author":"De Bundel","year":"2008","journal-title":"CNS Neurosci Ther."},{"key":"10.1007\/s13311-018-0613-8_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther."},{"key":"10.1007\/s13311-018-0613-8_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/cn500363g","article-title":"The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives","volume":"6","author":"Kaur","year":"2015","journal-title":"ACS Chem Neurosci."},{"key":"10.1007\/s13311-018-0613-8_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell."},{"key":"10.1007\/s13311-018-0613-8_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.coph.2009.09.008","article-title":"Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function","volume":"10","author":"Fiorentini","year":"2010","journal-title":"Curr Opin Pharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1523\/JNEUROSCI.23-03-01006.2003","article-title":"Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion","volume":"23","author":"Narita","year":"2003","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-018-0613-8_bib45","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/npp.2014.51","article-title":"Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone","volume":"39","author":"Leggio","year":"2014","journal-title":"Neuropsychopharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.0000047880.78462.0E","article-title":"Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR","volume":"41","author":"Zeng","year":"2003","journal-title":"Hypertension."},{"key":"10.1007\/s13311-018-0613-8_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neulet.2008.08.021","article-title":"Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats","volume":"444","author":"Jenkins","year":"2008","journal-title":"Neurosci Lett."},{"key":"10.1007\/s13311-018-0613-8_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(93)90902-Y","article-title":"Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats","volume":"613","author":"Mendelsohn","year":"1993","journal-title":"Brain Res"},{"key":"10.1007\/s13311-018-0613-8_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00165730","article-title":"DuP 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum","volume":"345","author":"Dwoskin","year":"1992","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2013.07.016","article-title":"Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA","volume":"76","author":"Dominguez-Meijide","year":"2014","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0613-8_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochem Pharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/syn.20130","article-title":"Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions","volume":"56","author":"Broening","year":"2005","journal-title":"Synapse."},{"key":"10.1007\/s13311-018-0613-8_bib53","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/syn.20952","article-title":"Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity","volume":"65","author":"Gross","year":"2011","journal-title":"Synapse."},{"key":"10.1007\/s13311-018-0613-8_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.expneurol.2013.10.014","article-title":"The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism","volume":"250","author":"Sonsalla","year":"2013","journal-title":"Exp Neurol."},{"key":"10.1007\/s13311-018-0613-8_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-9-103","article-title":"Prevention of methamphetamine-induced microglial cell death by TNF-alpha and IL-6 through activation of the JAK-STAT pathway","volume":"9","author":"Coelho-Santos","year":"2012","journal-title":"J Neuroinflamm."},{"key":"10.1007\/s13311-018-0613-8_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157015911795017353","article-title":"Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity","volume":"9","author":"Kanthasamy","year":"2011","journal-title":"Curr Neuropharmacol."},{"key":"10.1007\/s13311-018-0613-8_bib57","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1471-4159.1996.67020593.x","article-title":"Modification of dopamine transporter function: effect of reactive oxygen species and dopamine","volume":"67","author":"Berman","year":"1996","journal-title":"J Neurochem."},{"key":"10.1007\/s13311-018-0613-8_bib58","doi-asserted-by":"crossref","first-page":"30049","DOI":"10.18632\/oncotarget.9174","article-title":"Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging","volume":"7","author":"Rodriguez-Perez","year":"2016","journal-title":"Oncotarget."},{"key":"10.1007\/s13311-018-0613-8_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbi.2017.02.013","article-title":"Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures","volume":"62","author":"Dominguez-Meijide","year":"2017","journal-title":"Brain Behav Immun."},{"key":"10.1007\/s13311-018-0613-8_bib60","doi-asserted-by":"crossref","first-page":"30A","DOI":"10.1016\/j.amjcard.2009.10.009","article-title":"Renin-angiotensin system blockade and cardiovascular and renal protection","volume":"105","author":"Hoogwerf","year":"2010","journal-title":"Am J Cardiol."},{"key":"10.1007\/s13311-018-0613-8_bib61","first-page":"226","article-title":"Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease","volume":"1","author":"Labandeira-Garcia","year":"2012","journal-title":"Am J Neurodegener Dis."},{"key":"10.1007\/s13311-018-0613-8_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2006.03.004","article-title":"Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism","volume":"51","author":"Munoz","year":"2006","journal-title":"Neuropharmacology."},{"key":"10.1007\/s13311-018-0613-8_bib63","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1074\/jbc.M307657200","article-title":"NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia","volume":"279","author":"Qin","year":"2004","journal-title":"J Biol Chem."},{"key":"10.1007\/s13311-018-0613-8_bib64","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neurobiolaging.2006.02.018","article-title":"Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons","volume":"28","author":"Rey","year":"2007","journal-title":"Neurobiol Aging."},{"key":"10.1007\/s13311-018-0613-8_bib65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12974-017-1009-0","article-title":"Asiatic acid attenuates methamphetamine- induced neuroinflammation and neurotoxicity through blocking of NF-kB\/ STAT3\/ERK and mitochondria-mediated apoptosis pathway","volume":"14","author":"Park","year":"2017","journal-title":"J Neuroinflamm."},{"key":"10.1007\/s13311-018-0613-8_bib66","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/sctm.16-0382","article-title":"Angiotensin II causes apoptosis of adult hippocampal neural stem cells and memory impairment through the action on AMPK-PGC1a signaling in heart failure","volume":"6","author":"Kim","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1007\/s13311-018-0613-8_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-016-9647-z","article-title":"Melatonin protects SH-SY5Y neuronal cells against methamphetamine-induced endoplasmic reticulum stress and apoptotic cell death","volume":"31","author":"Wongprayoon","year":"2017","journal-title":"Neurotox Res."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-0613-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923015805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-0613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:06:16Z","timestamp":1761807976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923015805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1878747923015805"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-0613-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain Renin\u2013Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-0613-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}